Tag: treatment

0 0 0 Comment
Posted in HEADLINES

NanoVibronix stock triples in very active trading after upbeat report on UTI treatment

Shares of NanoVibronix Inc. NAOV, +248.14% more than tripled in very volatile and active afternoon trading Friday, after the company…

0 0 0 Comment
Posted in HEADLINES

Kadmon’s graft-versus-host treatment gets FDA approval

Kadmon Holdings Inc. KDMN, +20.56% said Friday that Rezurock, its treatment of chronic graft-versus-host disease (cGVHD) in adjusts and pediatric…

0 0 0 Comment
Posted in HEADLINES

Mizuho: Merck withdrawing Keytruda as a gastric cancer treatment won’t impact the stock

Shares of Merck & Co. Inc. MRK, +0.78% were up 0.7% in trading on Friday, the day after the company…

0 0 0 Comment
Posted in HEADLINES

Vir’s stock gains on early results from clinical trials for its hepatitis B treatment candidate

Shares of Vir Biotechnology Inc. VIR, -8.23% gained 3.1% in premarket trading on Friday after the company shared positive data…

0 0 0 Comment
Posted in HEADLINES

Edesa Biotech shares jump 14% premarket after early review of COVID treatment finds it should continue trial

Edesa Biotech Inc. shares EDSA, -2.11% jumped 14% premarket on Friday, after the Canadian biotech, which is listed on Nasdaq,…

0 0 0 Comment
Posted in HEADLINES

Merck enters $1.2 billion agreement to supply U.S. government with potential COVID-19 treatment

Shares of Merck & Co. Inc. MRK, -0.55% rose 0.9% in premarket trading Wednesday, after the drug maker announced a…

0 0 0 Comment
Posted in HEADLINES

U.S. stops distributing Lilly’s COVID-19 antibody therapy in six states, instead recommends Regeneron’s treatment

The U.S. government said this week it is halting distribution of Eli Lilly & Co.’s LLY, +0.62% COVID-19 antibody treatment…

0 0 0 Comment
Posted in HEADLINES

Emergent says experimental COVID-19 treatment failed in Phase 3 trial

Emergent BioSolutions Inc. EBS, -13.40% said Friday that its experimental COVID-19 treatment did not demonstrate a clinical benefit in a…

0 0 0 Comment
Posted in HEADLINES

Biogen shares jump 9% after FDA extends review period for Alzheimer’s treatment

Biogen Inc. shares BIIB, +5.50% rose 9% Friday, after the company said the U.S. Food and Drug Administration has extended…

0 0 0 Comment
Posted in HEADLINES

Vir, GSK’s experimental COVID-19 treatment moves into a Phase 3 clinical trial

Shares of Vir Biotechnology Inc. VIR, +0.69% gained 1.3% in premarket trading on Friday, the day after the biotech and…

0 0 0 Comment
Posted in HEADLINES

Five Prime’s stock rockets fourfold after positive trial results from cancer treatment, analyst upgrade

Shares of Five Prime Therapeutics Inc. FPRX, -2.73% blasted 314% higher in premarket trading Wednesday, after the company said its…

0 0 0 Comment
Posted in HEADLINES

Bluebird bio’s stock plunges after submission delay of sickle cell disease treatment

Shares of Bluebird bio Inc. BLUE, -14.77% traded 15.1% into the red in morning trading Thursday, after the gene therapy…